ABOUT ELITE
Overview
Our Facility
Management & Key Employees
Our Board
Careers
PRODUCTS
PIPELINE
Generic
Branded
TECHNOLOGY
Technology Overview
How It Works
One Bead System
Two Bead System
INVESTOR RELATIONS
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
HOME
|
CAREERS
|
CONTACT
|
NEWS
|
Skip to content
About Elite
Overview
Management & Key Employees
Our Board
Careers
Products
Pipeline
Generic
Branded
Technology
Technology Overview
How It Works
One Bead System
Two Bead System
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
Investor Relations
Press Releases
Events &Presentations
SEC Filings
ShareholderMeeting
GovernanceDocuments
Investor Contacts
Email Alerts
Press Releases
Select:
Show All
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Archived
Mar 10, 2014
Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally
Feb 18, 2014
Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201
Feb 10, 2014
lite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014
Nov 14, 2013
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2014
Aug 12, 2013
Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations
Aug 05, 2013
Elite Pharmaceuticals, Inc. Appoints Nasrat Hakim as President and Chief Executive Officer
Jun 21, 2013
Elite Pharmaceuticals, Inc. Reports Financial Results for the
Jun 19, 2013
Elite Pharmaceuticals, Inc. Announces 2013 Fiscal Year End Conference Call on Monday, June 24, 2013
Jun 10, 2013
Elite Laboratories Files Citizen Petition With The Fda On Brompheniramine Maleate And Pseudoephedrine Hcl Extended Release
May 21, 2013
Elite Pharmaceuticals Announces Change In Executive Leadership
12
13
14
15
16
17
18
19
20
21
22
<<
<
>
>>
Back to top
Privacy